Published in Biol Blood Marrow Transplant on November 02, 2013
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants | NCT00106925
A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children. Biol Blood Marrow Transplant (2015) 0.75
Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors. J Clin Oncol (2016) 0.75
Interpretative strategies for lung function tests. Eur Respir J (2005) 21.50
Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation. Am J Respir Crit Care Med (2005) 1.41
Implications of early airflow decline after myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant (2004) 1.14
A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation. Transplantation (1992) 1.13
Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant (2004) 1.05
Late pulmonary, cardiovascular, and renal complications after hematopoietic stem cell transplantation and recommended screening practices. Hematology Am Soc Hematol Educ Program (2008) 1.05
Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation. Biol Blood Marrow Transplant (2006) 1.04
Evaluation of pulmonary complications after bone marrow transplantation: the role of pretransplant pulmonary function tests. Bone Marrow Transplant (1992) 1.04
Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2005) 1.03
Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol (1998) 1.02
Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre. Bone Marrow Transplant (2004) 1.01
Late pulmonary complications after allogeneic hematopoietic stem cell transplantation: diagnosis, monitoring, prevention, and treatment. Semin Hematol (2012) 0.98
Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients. J Clin Oncol (1998) 0.96
Late pulmonary impairment following allogeneic bone marrow transplantation. Eur J Med Res (1996) 0.93
Lung function abnormalities after bone marrow transplantation in children: has the trend recently changed? Chest (2001) 0.91
Pulmonary function changes in long-term survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys (1996) 0.89
Pulmonary complications and respiratory function changes after bone marrow transplantation in children. Eur Respir J (1997) 0.89
Pulmonary function abnormalities after allogeneic marrow transplantation: a systematic review and assessment of an existing predictive instrument. Bone Marrow Transplant (2002) 0.87
Pulmonary function changes in long-term survivors of chronic myelogenous leukemia after allogeneic bone marrow transplantation: a Taiwan experience. Cancer Invest (2002) 0.85
Cigarette smoking and outcomes after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2011) 0.84
Pretransplant pulmonary function tests predict risk of mortality following fractionated total body irradiation and allogeneic peripheral blood stem cell transplant. Int J Radiat Oncol Biol Phys (2006) 0.82
Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplant. Bone Marrow Transplant (2007) 0.80
Lung function before and after pediatric allogeneic hematopoietic stem cell transplantation: a predictive role for DLCOa/VA. J Pediatr Hematol Oncol (2012) 0.77
Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committee. Biol Blood Marrow Transplant (2014) 0.99
Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research. Biol Blood Marrow Transplant (2013) 0.93
Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma. Biol Blood Marrow Transplant (2014) 0.78
Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis. Biol Blood Marrow Transplant (2014) 0.78
New cancers after autotransplantations for multiple myeloma. Biol Blood Marrow Transplant (2014) 0.75
Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation. Cancer (2017) 0.75
ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia - a report from the acute leukemia working party of the EBMT. Am J Hematol (2017) 0.75
Acquired RhD mosaicism identifies fibrotic transformation of thrombopoietin receptor-mutated essential thrombocythemia. Transfusion (2017) 0.75
Minor ABO Incompatibility Does Not Impact Nonrelapse Mortality in T Cell-Depleted Human Leukocyte Antigen-Matched Sibling Transplantation. Biol Blood Marrow Transplant (2015) 0.75